NCT02191176View on ClinicalTrials.gov

Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

Dextromethorphan syrup - low dose

DRUG

Dextromethorphan syrup - high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02191176 - Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter